Organization
Northwestern University Feinberg School of Medicine
43 abstracts
Abstract
ECOG-ACRIN EAZ171: Prospective validation trial of germline variants and taxane type in association with taxane-induced peripheral neuropathy (TIPN) in Black women with early-stage breast cancer.Org: Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN, Dana-Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Malden, MA,
Abstract
Prescription drug monitoring program mandates and opioid prescriptions received by patients dying of cancer.Org: Weill Cornell Medicine, University of Alabama at Birmingham, Albert Einstein College of Medicine, The University of Texas MD Anderson Cancer Center, Harvard Pilgrim Health Care Institute,
Abstract
Risk of significant functional impairment across cancer diagnosis and care continuum.Org: Dept. of Physical Therapy and Human Movement Sciences, Northwestern University Feinberg School of Medicine, Dept. of Medical Social Sciences, Northwestern University, Department of Medical Social Sciences,
Abstract
Evaluation of drug tolerability as a function of toxicity and quality of life in patients enrolled on I-SPY2.Org: University of California, San Francisco Department of Surgery, University of California, San Francisco, Susan G. Komen, UCSF Breast Science Advocacy Core, Mayo Clinic - Department of Surgical Oncology,
Abstract
EROS: Engendering reproductive health within oncologic survivorship—ECOG-ACRIN E1Q11 paradoxical provision of reproductive health.Org: Cook County Hospital, Dana-Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Lewis Cancer & Research Pavilion at St. Joseph's Candler/GA NCORP, SHCC MU-NCORP,
Abstract
Association of symptom severity, anxiety, and health literacy with portal usage among patients with cancer.Org: Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Northwestern University, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Department of Medical Social Sciences,
Abstract
If you build it, they will come: Success of the EROS (Engendering Reproductive Health Within Oncologic Survivorship)—ECOG-ACRIN E1Q11 in recruitment of minority patients.Org: Cook County Hospital, Dana-Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Lewis Cancer & Research Pavilion at St. Joseph's Candler/GA NCORP, SHCC MU-NCORP,
Abstract
EROS: Engendering reproductive health within oncologic survivorship—ECOG-ACRIN E1Q11 assessing discrepancy in clinician-patient importance of sexuality over 2 years post-cancer diagnosis.Org: John H. Stroger, Jr. Hospital of Cook County, Dana-Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, University of Illinois Urbana-Champaign, Lewis Cancer & Research Pavilion at St. Joseph's Candler/GA NCORP,
Abstract
Impact of intratumor heterogeneity (ITH) on survival outcomes in patients with non-small cell lung cancer (NSCLC) with high tumor mutational burden (TMB-H).Org: Northwestern University Feinberg School of Medicine,
Abstract
Oncology triage utilization among patients with gynecologic cancers.Org: Northwestern Memorial Hospital, Chicago, IL, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University,
Abstract
Clinical, environmental, genetic, and genomic profile of men with early-onset aggressive prostate cancer: A final report.Org: Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Dana-Farber Cancer Institute, Michigan Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, MI,
Abstract
Comparing rates of immune checkpoint inhibitor toxicity in different treatment settings (neoadjuvant, adjuvant, and palliative) in non-small cell lung cancer (NSCLC): A meta-analysis of phase III clinical trials.Org: Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital, Chicago, IL, John H. Stroger, Jr. Hospital of Cook County,
Abstract
Surgical window of opportunity clinical trial of abemaciclib and letrozole for endometrioid adenocarcinoma of the endometrium.Org: Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, China, Northwestern Memorial Hospital, Chicago, IL, Chicago, IL, Il-Yang Pharmaceuticals, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center,
Abstract
Sacituzumab govitecan (SG) + pembrolizumab (pembro) in first-line (1L) metastatic non-small cell lung cancer (mNSCLC) with PD-L1 ≥ 50%: Cohort A of EVOKE-02.Org: Northwestern University Feinberg School of Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea, Regional and Virgen de la Victoria University Hospitals, IBIMA, Hospital Clínic de Barcelona, IDIBAPS,
Abstract
Double lung transplantation in patients with recent history of malignancy.Org: Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL, Feinberg School of Medicine,
Abstract
Impact of neighborhood deprivation on disability free survival in patients with aggressive B cell non-Hodgkin lymphoma.Org: Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, Feinberg School of Medicine, Northwestern University, Northwestern University Feinberg School of Medicine,
Abstract
A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The vulvar cancers.Org: Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, Il-Yang Pharmaceuticals, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, Seattle Gummy Company,
Abstract
Artificial intelligence (AI) analysis of tumor-infiltrating lymphocytes (TILs) in hematoxylin and eosin (H&E) slides to explore immune phenotypes in papillary thyroid cancer.Org: Lincoln Medical and Mental Health Center, Northwestern University Feinberg School of Medicine, Ascension Saint Francis Hospital, Lunit Inc., Oncology Therapeutic Development,
Abstract
The impact of the 4R Oncology model on OncotypeDx turnaround time.Org: The Permanente Medical Group Consulting Services, Northwestern University Feinberg School of Medicine, Center for Business Models on Healthcare, Kaiser Permanente Northern California, Genentech Inc.,
Abstract
The implementation of a self-care tool for patients that may reduce clinician burden.Org: Department of Medicine, Icahn School of Medicine at Mount Sinai, The Permanente Medical Group Consulting Services, Kaiser Permanente Oakland Medical Center, Sacramento Medical Center, Kaiser Permanente Northern California,
Abstract
Open-label study of darolutamide plus androgen-deprivation therapy (ADT) vs ADT in metastatic hormone-sensitive prostate cancer using an external control arm (ARASEC).Org: Carolina Urologic Research Center, Northwestern University Feinberg School of Medicine, Brigham and Women’s Hospital, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, University of Michigan,
Abstract
A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The desmoid tumors (cohort 27).Org: Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, UC San Diego Moores Cancer Center, University of Kansas Medical Center, Department of Biostatistics & Data Science, Loma Linda University Department of Radiation Technology,
Abstract
Systematic review and meta-analysis of the accuracy and applicability of blood-based multi-cancer early detection (MCED) in the general population.Org: Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Department of Medicine, Icahn School of Medicine at Mount Sinai, Northwestern University Feinberg School of Medicine, Louis A Weiss Memorial Hospital, Ascension Saint Francis Hospital,
Abstract
Longitudinal transcriptome profiling of localized hormone-sensitive tumors in treatment-naïve ENACT patients with prostate cancer with and without enzalutamide (ENZA).Org: Northwestern University Feinberg School of Medicine, Carolina Urologic Research Center, Veracyte, Inc., Astellas Pharma Inc., Pfizer Inc., London, United Kingdom,
Abstract
Pirtobrutinib in covalent BTK-inhibitor (cBTKi) pre-treated mantle cell lymphoma (MCL): Updated results and subgroup analysis from the phase 1/2 BRUIN study with >3 years follow-up from start of enrollment.Org: Medical College of Wisconsin, Milwaukee, WI, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland, IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli” and Dipartimento di Medicina Specialistica,
Abstract
A randomized phase II study comparing single-agent olaparib, single-agent cediranib, and the combinations of cediranib/olaparib, olaparib/durvalumab (MEDI4736), cediranib/durvalumab (MEDI4736), and olaparib/AZD5363 (capivasertib) in women with recurrent, persistent, or metastatic endometrial cancer.Org: Cedars-Sinai Medical Center, University of Iowa Hospitals and Clinics, NRG Oncology, University of Texas MD Anderson Cancer Center, Stephenson Cancer Center/University of Oklahoma Health Sciences Center and Sarah Cannon Research Institute,
Abstract
Incidence, landscape and survival outcome of de novo malignancy after double lung transplantation.Org: Northwestern University Feinberg School of Medicine, Kyungpook National University Hospital, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center,
Abstract
Ibrutinib dose modifications for management of cardiac adverse events in patients with B-cell malignancies: Pooled analysis of 10 clinical trials.Org: Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, CLL Center, Dana-Farber Cancer Institute,
Abstract
Epidemiologic effectors on the breast tumor microenvironment: Results from the Cancer Prevention Study-II and -3 cohorts.Org: John H. Stroger, Jr. Hospital of Cook County, Northwestern University Feinberg School of Medicine, American Cancer Society, National Cancer Institute, Vilnius, Lithuania, Robert H. Lurie Comprehensive Cancer Center, Northwestern University,
Abstract
Inverse association of post-transplant malignancy and graft failure on survival outcome following double lung transplantation.Org: Northwestern Memorial Hospital, Chicago, IL, Northwestern University Feinberg School of Medicine, Semmelweis Egyetem Pulmonologiai Klinika, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center,
Abstract
Machine learning models based on radiomics features to predict treatment response, biomarker status, and bone metastasis in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs).Org: Northwestern University Feinberg School of Medicine, Northwestern Medicine Devleopmental Therapeutics Institute, Northwestern Memorial Hospital, Chicago, IL, AMITA Health Saint Francis Hospital Evanston, Kyungpook National University Hospital,
Abstract
Adherence to mercaptopurine (6-MP) and habit strength in pediatric acute lymphoblastic leukemia (ALL).Org: Department of Medical Education, Northwestern University Feinberg School of Medicine, Division of Hematology, Oncology, and Stem Cell Transplant, Ann and Robert H Lurie Children's Hospital of Chicago, Ann & Robert H. Lurie Children’s Hospital of Chicago,
Abstract
Systematic review and meta-analysis of accuracy of tumor origin detection in blood cell-free DNA (cfDNA)-based multi-cancer early detection (MCED) assays in the general population.Org: Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital, Chicago, IL, Louis A Weiss Memorial Hospital, Ascension Saint Francis Hospital,
Abstract
Heterofunctional polymeric degrading chimeras (HYDRAC) for targeted protein degradation.Org: Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University Feinberg School of Medicine,
Abstract
Relationship between efficacy of phase I/II drug ispinesib in medulloblastoma, molecular subtypes, and p53-mutant status.Org: Duke-NUS Medical School, Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, Baylor College of Medicine, Pediatric Brain Tumor Research Office, SingHealth Duke-NUS Academic Medical Center,
Abstract
Transcriptomic heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer.Org: Veracyte, Inc., Ghent University Hospital, Northwestern University Feinberg School of Medicine, Helen Diller Family Comprehensive Cancer Center, Oncology Institute of Southern Switzerland,
Abstract
Artificial intelligence (AI) –powered H&E whole-slide image (WSI) analysis of tertiary lymphoid structure (TLS) correlates with immune phenotype and related molecular signatures in non–small-cell lung cancer.Org: Oncology Therapeutic Development, Lunit Inc., Northwestern University Feinberg School of Medicine,
Abstract
The impact of 4R Oncology Model on patient self management and satisfaction in lung versus breast cancer.Org: Center for Business Models on Healthcare, Northwestern University Feinberg School of Medicine, Kaiser Permanente Oakland Medical Center, Division of Research Services, Kaiser Permanente Northern California,
Abstract
Effect of pandemic-related reductions in cancer care delivery on different US health systems.Org: Northwestern University Feinberg School of Medicine, American College of Surgeons, University of Kentucky College of Medicine, Yale School of Medicine,
Abstract
Post-double lung transplantation survival outcomes of bilateral lung cancer and incidence of post-transplant lung cancer.Org: Kyungpook National University Hospital, Daegu-Gyeongbuk Medical Innovation Foundation, Northwestern University Feinberg School of Medicine, Chicago, IL, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center,
Abstract
The impact of 4R Care Delivery Model on timing and sequence of bone density screening among breast cancer patients.Org: Kaiser San Francisco, Northwestern University Feinberg School of Medicine, Center for Business Models on Healthcare, Division of Research Services, Kaiser Permanente Northern California,
Abstract
ARTIFICIAL INTELLIGENCE (DEEP NEURAL NETWORK ANALYSIS) AS A SKIN OUTCOME: RESULTS OF AN OPEN-LABEL BELUMOSUDIL TRIAL IN PATIENTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSISOrg: Northwestern University Feinberg School of Medicine, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA, Columbia University - Mailman School of Public Health, Kansas City Physician Partners,
Abstract
BASELINE FINDINGS FROM A PATIENT-CENTERED, TREAT-TO-TARGET APPROACH IN RHEUMATOID ARTHRITIS Org: Northwestern University Feinberg School of Medicine, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, CJE SeniorLife, Chicago, United States,